ERBB2 and neoplasm: The model demonstrated positive predictive values of 85.9% for Luminal A, 87.8% for Luminal B, 76.9% for Normal-like, 98.2% for Basal-like, and 92.9% for HER-2 positive tumours (Fig 4).